Td Asset Management Inc Aptinyx Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$3.99 - $19.33 $45,122 - $218,602	-11,309 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$16.15 - $28.93 $9,690 - $17,358	600 Added 5.6%	11,309 $187,000
Q3 2018 Nov 01, 2018	BUY	$20.21 - $31.85 $5,133 - $8,089	254 Added 2.43%	10,709 $310,000
Q2 2018 Jul 31, 2018	BUY	$19.83 - $24.17 $207,322 - $252,697	10,455 New	10,455 $253,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.